Results 161 to 170 of about 30,734 (250)
Brimonidine Allergy Presenting as Corneal Subepithelial Infiltrates: A Case Report. [PDF]
Korean J OphthalmolLee JY, Kim GA, Han SB.
europepmc +1 more source
Nimodipine Nanoparticles: A Promising Approach for Glaucoma Management. [PDF]
PharmaceuticsMaria DN +3 more
europepmc +1 more source
Interspecies scaling of suprachoroidal drug delivery using ocular geometry and drug physicochemical properties. [PDF]
Sci RepPatil MA +3 more
europepmc +1 more source
Comment on "Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate".
Indian J Ophthalmol, 2013 Arunachalam C.
europepmc +1 more source
On the aetiology of myopia: aspects of structure, function and epidemiology [PDF]
Gilmartin, Bernard
core
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Journal of Pharmaceutics, 2018
The use of gelatin has been gaining recognition in ocular delivery for its safety profile and biocompatible properties. Timolol Maleate (TM) is an anti‐glaucoma drug possessing poor corneal penetration while causing eye irritation making it an ideal ...
Miral Shokry, R. Hathout, S. Mansour
semanticscholar +3 more sources
The use of gelatin has been gaining recognition in ocular delivery for its safety profile and biocompatible properties. Timolol Maleate (TM) is an anti‐glaucoma drug possessing poor corneal penetration while causing eye irritation making it an ideal ...
Miral Shokry, R. Hathout, S. Mansour
semanticscholar +3 more sources
Chitosan Nanoparticles for Prolonged Delivery of Timolol Maleate
Drug Development and Industrial Pharmacy, 2007Timolol maleate-loaded chitosan (CS) nanoparticles were prepared by desolvation method. Experimental variables such as molecular weight of CS and amount of crosslinking agent were varied to study their effect on drug entrapment efficiency, size and release rates of nanoparticles.
Sunil A, Agnihotri, Tejraj M, Aminabhavi
openaire +4 more sources
Journal of Biomaterials Science. Polymer Edition, 2023
Reducing intraocular pressure (IOP) with eye drops is one of the most common ways to control glaucoma. Low bioavailability and high frequency of administration in eye drops are major challenges in ocular pharmacotherapy. Contact lenses have attracted the
Maryam Sadat Hosseini +6 more
semanticscholar +1 more source
Reducing intraocular pressure (IOP) with eye drops is one of the most common ways to control glaucoma. Low bioavailability and high frequency of administration in eye drops are major challenges in ocular pharmacotherapy. Contact lenses have attracted the
Maryam Sadat Hosseini +6 more
semanticscholar +1 more source